首页> 外文期刊>Fetal and pediatric pathology >Role of GJB2 and GJB6 in Iranian Nonsyndromic Hearing Impairment: From Molecular Analysis to Literature Reviews
【24h】

Role of GJB2 and GJB6 in Iranian Nonsyndromic Hearing Impairment: From Molecular Analysis to Literature Reviews

机译:GJB2和GJB6在伊朗非正系听力障碍中的作用:从分子分析到文献评论

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Hearing impairment (HI) is a heterogeneous disorder. GJB2 and GJB6 genes are typically the first line of genetic screening before proceeding to any massive parallel sequencing. We evaluated the clinical utility of GJB2 and GJB6 testing in the Iranian population. Methods: GJB2 and GJB6 were sequenced. PubMed and Google Scholar were searched for Iranian publications on deletions in the DFNB1 locus. Results: We detected mutations of GJB2 in 16.5%, and no mutations of GJB6. Literature review revealed no reports of mutations of GJB6 in the Iranian population. Conclusion: This data and literature reviews indicate that GJB6 is not commonly responsible for Iranian nonsyndromic HI. Hence, the clinical utility of GJB6 genetic analysis as a first line for HI evaluation does not have the same utility as GJB2. The study is consistent with recent studies emphasizing the role of ethnicity in the selection of HI genetic testing strategy.
机译:背景:听力障碍(HI)是一种异质疾病。 GJB2和GJB6基因通常是第一线遗传筛选,然后进入任何大规模平行测序。 我们评估了GJB2和GJB6测试在伊朗人口中的临床效用。 方法:测序GJB2和GJB6。 PubMed和Google Scholar在DFNB1基因座中的删除中搜索了伊朗出版物。 结果:我们检测到GJB2的突变为16.5%,而且没有GJB6的突变。 文献综述显示没有伊朗人口中GJB6的突变报告。 结论:此数据和文献综述表明GJB6不普遍负责伊朗非合成瘤嗨。 因此,GJB6遗传分析作为HI评估的第一线的临床效用与GJB2没有相同的效用。 该研究与最近的研究一致,强调种族在选择Hi遗传检测策略中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号